33
Thamonwan Theerabunchorn 04/03/2009

Hyperlipidimia and Statins

Embed Size (px)

Citation preview

Page 1: Hyperlipidimia and Statins

Thamonwan Theerabunchorn 04/03/2009

Page 2: Hyperlipidimia and Statins

OBJECTIVE

TO FIND OUT THESE :

1.What is hyperlipidimia ?

2.What happen after hyperlipidimia ?

3.What is/are differentiation

of each statin drug ?

4.How to beattle ?

Page 3: Hyperlipidimia and Statins

1

Page 4: Hyperlipidimia and Statins

SO LOW SO GOOD

Normal

Abnormal

Page 5: Hyperlipidimia and Statins

HDL

SO HIGH

SO GOOD

Abnormal

Normal

Page 6: Hyperlipidimia and Statins

Normal

Abnormal

LDL < 130 mg/dL

Page 7: Hyperlipidimia and Statins

Normal

Abnormal

Page 8: Hyperlipidimia and Statins

12

Page 9: Hyperlipidimia and Statins

ภาวะไขมันในเลอืดสูง

สะสมตามหลอดเลอืดแดงต่าง ๆ

หัวใจ สมอง

ปลายมือปลายเท้า

CARDIOVASCULAR DISEASE

(*** CVD ***)

Page 10: Hyperlipidimia and Statins

Normal artery

• smooth

• flexible

Abnormal artery

• rough

• rigid

Page 11: Hyperlipidimia and Statins

CVD at Heart Artery

• Myocardial Infraction

• Anginapectoris

Page 12: Hyperlipidimia and Statins

CVD at Peripheral Artery

• เหน็บชา มือ เท้า• แผล / ตดิเชือ้

Page 13: Hyperlipidimia and Statins

CVD at Cerebral Artery

• อมัพฤก / อมัพาต• ความจ าเส่ือม

• ปากเบีย้ว พูดไม่ชัด

Page 14: Hyperlipidimia and Statins

RISK FACTOR

POSITIVE NEGATIVE

• AGE

• Low HDL Cholesterol

• Cigarette smoking

• Hypertention

• Genetics

• High HDL Cholesterol

Page 15: Hyperlipidimia and Statins

RISK FACTOR

MEN WOMENCITERIA

• AGE

• Low HDL Cholesterol

• Cigarette smoking

• Hypertention

• Genetics

• >,= 45 years

• < 40 mg/dl

• YES !

• BP > 140/90 mm Hg

or

taking

hypertensive

medicind

• YES !

• >,= 55 years

• < 40 mg/dl

• YES !

• BP > 140/90 mm Hg

or

taking

hypertensive

medicind

• YES !

Page 16: Hyperlipidimia and Statins

GOAL & MANAGEMENT

Risk category : CHD (10 – year risk > 20 percent)

• LDL goal : < 100 mg/dl

• Therapeutic Life Style Change (TLC) : LDL >,= 100 mg/dl

• Drug Therapy : LDL >,= 130 mg/dl

Page 17: Hyperlipidimia and Statins

GOAL & MANAGEMENT

Risk category : 2 or more risk factors (10 – year risk < 20 percent)

• LDL goal : < 130 mg/dl

• Therapeutic Life Style Change (TLC) : LDL >,= 130 mg/dl

• Drug Therapy :

1. LDL >,= 130 mg/dl for 10 – year risk of 10 to 20 percent

2. LDL >,= 160 mg/dl for 10 – year risk of < 10 percent

Page 18: Hyperlipidimia and Statins

GOAL & MANAGEMENT

Risk category : 0 – 1 risk factor

• LDL goal : < 160 mg/dl

• Therapeutic Life Style Change (TLC) : LDL >,= 160 mg/dl

• Drug Therapy : LDL >,= 190 mg/dl

Page 19: Hyperlipidimia and Statins

13

Page 20: Hyperlipidimia and Statins

STATIN DRUG THERAPY

• Mechanism of Action

HMG-CoA

Mevalonate

HMG – CoA Reductase

Statin Drug

Statin = HMG-CoA Reductase Inhibitor

Cholesterol&

Ubiquinone (CoQ10)

1

2 3

Page 21: Hyperlipidimia and Statins

TYPE OF STATIN

TYPE I TYPE II

Rosuvastatin

Atorvastatin

(Fermentation Derivative) (Synthetics Group)

etc. : Lovastatin, Pravastatin : Fluvastatinetc.

Simvastatin

Page 22: Hyperlipidimia and Statins

Check ListDifferentiation

Simvastatin Atorvastatin Rosuvastatin

ED-List Yes No No

Cost(baht)/Tablet

(at start dose)0.40 - 0.80 30 - 35 40

Dose(mg/day)

required

to acchive

30% - 40%

LDL-Reduction

20 - 40 10 5 -10

Efficacy

of

LDL Reduction

(%)

35 - 41 39 39 - 45

D/I

(Drug

Interaction)CYP3A4 CYP3A4

CYP2C9

CYP2C19

notice

coz ADR related to dose then low dose low ADR

So

Atorvastatin & Rosuvastatin are ALTERNATIVE of Simvastatin

Page 23: Hyperlipidimia and Statins

DRUG INTERAC WITH HEPATIC ENZYME

CYP3A4 CYP3C9 CYP3C19

• Macrolides (azithromycin, clarithromycin,

erythromycin)

• Antifungals (itraconazole, ketoconazole, terbinafine)

• Calcium Antagonists (mibefradil, diltiazem,

verapamil, nifedipine, Lacidipine)

• Protease inhibitors (indinavir, ritonavir, nelfinavir,

saquinavir, amprenavir)

• Wafarin

• Sildenafil

• Cyclosporine• Tacrolimus

• Amiodarone

• Quinidine• Nefazodone

• Alprenolol

• Diclofenac

• Hexobabital

• Phenyltoin

• Tolbutamide

• Warfarin

• Diazepam

• Ibuprofen

• Mephenytoin

• Methylphenobabital

• Omeprazole

• Phenytoin

• Proguanyl

Page 24: Hyperlipidimia and Statins

ADVERSE DRUG REACTION

ADR(+++v+++)

+!!!!!!!!+

+!!!!+V

Page 25: Hyperlipidimia and Statins

ADVERSE DRUG REACTION (ADR)

• ปวดท้อง ท้องผูก ท้องเสีย คล่ืนไส้ อาเจียร และปวดศรีษะ

• อ่อนเพลีย • กล้ามเนือ้เป็นตะคริว • ปวดกล้ามเนือ้และข้อ ทัง้นี ้ถ้าเกิดภาวะไฟเบอร์ของกล้ามเนือ้ลายแตก ร่วมกับการมีหรือไม่มีภาวะไตวายเฉียบพลับจนสามารถตรวจพบสาร myoglobin ในปัสสาวะควรหยุดใช้ยาทันที

อาการที่พบบ่อย ได้แก่

อาการที่พบได้บ้าง ได้แก่

Page 26: Hyperlipidimia and Statins

HMG-CoA

HMG – CoA Reductase

Statin Drug

Cholesterol

&UBIQUINONE

1

2

MACHANISM OF MYOPHATY

Muscle Cell

Disturbance

MYOPHATY• ปวดกล้ามเนือ้

Page 27: Hyperlipidimia and Statins

14

Page 28: Hyperlipidimia and Statins

SIMVASTATIN BRAND IN THE MARKET

…BERLIN CO LTD,.

Page 29: Hyperlipidimia and Statins

SIMVASTATIN BRAND IN THE MARKET

…SILOM MEDICAL

Page 30: Hyperlipidimia and Statins

… GOVERNMENT PHARMACEUTICAL ORGANIZATION

GPO’s BRAND

Can

YOU

Remember

?

WHAT ABOUT OURS

Page 31: Hyperlipidimia and Statins

… GOVERNMENT PHARMACEUTICAL ORGANIZATION

Page 32: Hyperlipidimia and Statins

COMPETETIVE CHECK LIST

Check List

Differentiation

GPO Berlin Silom

StrengthCover All

(10,20,40,80 mg)

Cover All

(10,20,40,80 mg)

Cover All

(10,20,40,80 mg)

Price Flexibility Yes Yes Yes

Shelf Life 2 ปี เบือ้งต้น 3 ปี 3 ปี

Packaging Alu-Alu & Strip Alu-PVDC Alu-PVDC

Climate Change

ToleranceYes No No

Page 33: Hyperlipidimia and Statins